Home › NDC Lookup › RxCUI directory › RxCUI 351974

Minocycline 1 MG Oral Powder [Arestin] — RxCUI 351974

RxNorm drug concept · Semantic branded drug
RxCUI 351974 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351974
Official nameMinocycline 1 MG Oral Powder [Arestin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asArestin 1 MG Oral Powder; Arestin (minocycline hydrochloride) 1 MG Oral Powder
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Minocycline Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amzeeq is specifically approved to treat inflammatory acne lesions — the red, swollen bumps — in people 9 years and older with moderate to severe acne. It's not for blackheads or w...
  • What exactly is Amzeeq used for — is it just for acne?
  • Shake the can well before each use, then dispense a small amount — roughly the size of a cherry — onto your fingertips and rub it gently into your acne-affected skin. If you have b...
  • It's worth taking seriously. The propellant that pushes the foam out of the can is flammable, so you should stay away from open flames, candles, or cigarettes while you're applying...
📖 Read our full Minocycline Topical guide →

🕸️ Concept Web — How Minocycline 1 MG Oral Powder [Arestin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Minocycline 1 MG Oral Powder [Arestin] RxCUI 351974

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Minocycline 6980
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Arestin 352444
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Minocycline Oral Powder 378771
    • Minocycline Oral Powder Product 1295397
    • Minocycline Oral Product 1164754
    • Minocycline Oral Powder [Arestin] 403110
    • Arestin Oral Powder Product 1296449
    • Arestin Oral Product 1170112
    • Oral Powder 346289
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Minocycline 1 MG Oral Powder SCD · 351121
  • Minocycline 1 MG SCDC · 353349
  • Minocycline Oral Powder SCDF · 378771
  • Minocycline Oral Powder Product SCDG · 1295397
  • Minocycline Oral Product SCDG · 1164754

Brand-Name Concepts

  • Minocycline 1 MG [Arestin] SBDC · 575725
  • Minocycline Oral Powder [Arestin] SBDF · 403110
  • Arestin Oral Powder Product SBDG · 1296449
  • Arestin Oral Product SBDG · 1170112
  • Arestin BN · 352444

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 351974 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65976-0100-01 1 POWDER in 1 POUCH (65976-100-01) Arestin OraPharma, Inc. 2011-03-21
65976-0100-12 1 POUCH in 1 BOX (65976-100-12) / 1 TRAY in 1 POUCH / 12 PO... Arestin OraPharma, Inc. 2011-03-21
65976-0100-24 2 POUCH in 1 BOX (65976-100-24) / 1 TRAY in 1 POUCH / 12 PO... Arestin OraPharma, Inc. 2011-03-21
Observed labelers: OraPharma, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.